Congratulations to Li Peng, Chief Scientific Officer of #TBCPartner Palleon Pharmaceuticals, who was named to the 2024 PharmaVoice 100 list! Li is a trailblazer in the growing field of glyco-immunology, shaping Palleon's approach and increasing enthusiasm for others to learn more about the science behind it.
We’re proud to share that our Chief Scientific Officer, Li Peng, was named to this year’s PharmaVoice 100 list alongside other influential leaders in biopharma! Li is recognized for her outstanding commitment to progress the uncharted field of glyco-immunology, and for her tenacious spirit that has shaped and improved our platform. Li inspires all of us at Palleon, and we’re excited share her story with others. Read about it here: https://bit.ly/3ZPGoEq